MimioHealth is a health and wellness company focused on leveraging scientific research to develop nutritional supplements that mimic the beneficial effects of fasting. The company aims to harness the body's natural healing abilities through the use of bioactive ingredients like 1-MNA, a metabolite of vitamin B3, which has been shown to have anti-inflammatory, antioxidant, and lifespan-extending properties.

MimioHealth

Mimio Health is a nutraceutical company dedicated to the research and production of the world's first fasting mimetic supplement. Our supplement was designed from clinical research to replicate the cellular health benefits and lifespan-promoting effects of fasting without the need to fast.

Through years of research into human fasting we have uncovered a conserved metabolic program for cellular health and regeneration that underpins the beneficial effects of fasting. Our patent-pending fasting mimetic forumuation uses a rigorously selected combination of the same bioactive human metabolites that induce this regenerative "bio-program" to replicate the body’s natural response to fasting without having to fast. We have shown that our fasting mimetic is capable of extending the lifespan of model organisms by 96% and has powerful anti-inflammatory and antioxidant effects in human cells that could combat age-associated chronic inflammation and cellular damage allowing our customers to live longer, healthier lives.

Metric
Company Name	MimioHealth
Symbol
MSH ID	COM:MIMIOHEALTH
Market	PRIVATE
Sector	Consumer Goods
Industry	Health Supplements
Country	US
Stage
Employee Count	5
Website	mimiohealth.com
LinkedIn	mimiohealth
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MIMIOHEALTH

MimioHealth

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue